Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (3): 191-192.
LI Hongmei1, SI Junling1, WANG Yanmin2,*
Received:
2018-10-10
Revised:
2020-06-28
Online:
2019-03-20
Published:
2019-04-17
CLC Number:
LI Hongmei, SI Junling, WANG Yanmin. One Case of Pulmonary Interstitial Edema and Edema of Lower Extremities Induced by Sucrose Iron Injection[J]. Chinese Journal of Pharmacovigilance, 2019, 16(3): 191-192.
Add to citation manager EndNote|Ris|BibTeX
[1] 陈植. 不常见的药物性水肿[J].中级医刊,1990,(11):40-41. [2] 于步前,宋书凯.水肿机制与鉴别诊断[J].临床荟萃,1990,(7):305-306. [3] 吴小枫,林珍,史涛.蔗糖铁注射液致重症多形红斑型药疹1例[J].中国药物警戒,2017,14(7):443,445. [4] 王维忠. 102例药源性水肿文献分析[J]. 中国药业, 2004, 13(3):62-63. [5] 王少华. 肺水肿的X线表现[J]. 中国现代药物应用, 2009, 3(23):53-54. [6] Shiotani S, Kobayashi T, Hayakawa H, et al.Postmortem pulmonary edema: A comparison between immediate and delayed postmortem computed tomography[J]. Legal Medicine, 2011, 13(3):151-155. [7] Shin N Y, Hong Y J, Kim A H, et al.Diffuse Interstitial Infiltrative Lung Metastasis of Malignant Melanoma: a Case Report[J]. Korean Journal of Radiology Official Journal of the Korean Radiological Society, 2011, 12(2):252-255. [8] 向兴利, 杜智敏, 马志习, 等. 高原肺水肿的CT诊断[J]. 中华放射学杂志, 2002, 36(2):137-138. [9] 黄依莲. 肺水肿的影像学鉴别诊断[J]. 亚太传统医药, 2010, 6(6):117-119. [10] Hsu K F, Ou K W, Lee S C, et al.Re-expansion Pulmonary Edema After Insertion of Chest Tube for Pneumothorax[J]. The Journal of Trauma: Injury, Infection, and Critical Care, 2011, 70(3):761. [11] 苏宪英,石光,张欣,等.引起药物性水肿的常见药物及发生机制[J].中国民族民间医药,2016,25(6):163,165. [12] 郝爱华,曾庆娟,江洁.心源性肺水肿的影像学表现及其鉴别诊断[J].中国中西医结合影像学杂志,2014,12(5):518-520. [13] 杨作成. 小儿心源性肺水肿[J].实用儿科临床杂志,2011,26(22):1693-1695. [14] 凌文哲,金学荣,张海宇.药物过敏所致急性肺水肿的影像学特点分析[J].山东医药,2012,52(23):67-68. [15] 吴颖其, 姜玲, 张圣雨, 等.我院蔗糖铁注射液药物利用评价标准的建立及应用[J].中国药房, 2017, 28(2) :270-273. [16] 倪寂,冯伟民,范赟婷.2016年某院蔗糖铁注射液临床使用评价及分析[J].中国药业,2017,26(22):89-92. [17] 李春霞. 不同补铁途径治疗缺铁性贫血的临床研究[J].中国实用医药,2013,8(36):117-118. [18] Derman R, Roman E, Modiano M R, et al.A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia[J]. American Journal of Hematology, 2017, 92(3):286-291. |
[1] | LI Xinying, BAO Lei, LI Shuran, ZHAO Ronghua, SUN Jing, XIE Dan, BAO Yanyan, GUO Shanshan, CUI Xiaolan, GENG Zihan. Effect of Shufeng Jiedu Capsules on the Production of Specific Antibodies against Influenza A H1N1 Virus and the Mechanisms [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 841-850. |
[2] | WANG Xinwei, PENG Yifeng, SUN Jing, JI Zuen, BAO Lei, LUO Henglei, GENG Zihan, ZHANG Hujuan, LI Shuran, ZHANG Jingsheng, GUO Shanshan, CUI Xiaolan, ZHAO Ronghua. Effect of Yiye Anti-Influenza Capsules on Pneumonia Induced by Human Coronavirus 229E Infection in Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 851-855. |
[3] | XIE Rui, SUN Qiyue, LI Yanying, ZHANG Jingsheng, ZHAO Ronghua, GUO Shanshan, GENG Zihan, BAO Lei, GAO Shuangrong, CUI Xiaolan, XIE Dan, SUN Jing. Impacts of Shuangshenling Granules on a Cadmium-Induced Chronic Renal Failure Model of Mice [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 856-862. |
[4] | CHEN Siying, DING Xueli, LIU Shujia, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian. Modeling for Prediction of Cardiotoxicity of Chinese Herbal Medicines [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 869-875. |
[5] | CAI Haili, ZHANG Xiaomeng, LIU Yadi, CHEN Lijuan, WANG Yu, ZHANG Bing. Preventive Strategies for Anthracycline-Induced Cardiotoxicity Using Traditional Chinese Medicine via Ferroptosis Regulation [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 876-882. |
[6] | ZHENG Haiyun, WANG Zhigang, WU Hongwei, WANG Shaonan, WANG Bin. Identification of in vitro and in vivo Chemical Constituents of Buxin Anmian Decoction Based on UPLC-Q Exactive Orbitrap HRMS [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 883-888. |
[7] | SUN Ya, WANG Xu, SUN Zhi, ZHOU Yubing. Dose Analysis of Linezolid in Severe Patients with Sepsis Complicated with Acute Kidney Injury [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 889-895. |
[8] | SHI Qi, WANG Jianxin, WANG Guijie, LU Yueyang, ZHU Jiaxu, GAO Rui. Adjuvant Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Qingqi Huatan Pills: a Systematic Review [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 914-919. |
[9] | YING Jie, XU Xiaolong, LI Bo, LIU Tengwen, LIU Qingquan. Clinical Applications of Jinhua Qinggan Granules in the Treatment of Mild Influenza: a Meta-Analysis [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 920-923. |
[10] | KE Xiuqin, HAI Xuewu. 433 Cases of Adverse Drug Reactions Induced by Calcium Dobesilate Capsules [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 924-927. |
[11] | LIANG Jie. 172 Cases of Adverse Drug Reactions Induced by Antineoplastic Drugs [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 928-932. |
[12] | LIU Jiang, CHEN Jie, QIU Sihong, LI Na, ZHOU Ying, CHEN Yonggang, LUO Ji. Analysis of Adverse Drug Event Induced by Omacycline and Moxifloxacin Based on FAERS Databse [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 933-936. |
[13] | ZHAO Mudan, ZHU Minghui, ZHANG Huan, ZHAO Yuanyang, QIN Jing. Pharmaceutical Care of a Case of Diabetic Foot Infection Caused by Proteus penneri [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 937-940. |
[14] | ZHOU Yujie, HUANG Xiaojing, CHEN Mingyue, DU Pengqiang, WANG Aifeng. Two Cases of Severe Thrombocytopenia Caused by Cefoperazone Sulbactam Sodium [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 941-943. |
[15] | CHEN Huabao, LIU Wei, JIANG Ting, ZHENG Lingli, LI Jing. One Case of Acute Withdrawal Syndrome Caused by Naloxone [J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 944-946. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||